“DDP is an event that has for the past two decades been an important meeting place for drug delivery leaders.
Menu
The rapid growth of the biologics and biosimilars market has created a significant demand for self-injection devices for the treatment of chronic indications.
At the center of this exhibition are designs for high volume and high viscosity formulations.
The rapid growth of biologics and biosimilars has significantly increased the demand for self-injection devices for the treatment of chronic indications.
SHL will also show the highly-anticipated ENYA Platform, a smart add-on injection tracking offering developed in partnership with Innovation Zed Ltd.
Visit SHL at the Taipei Shangri-La’s Far Eastern Plaza Hotel to learn more about our devices, packaging solutions and innovative offers.
As a forward-looking company with extensive knowledge and experience, SHL delivers solutions for today on the path to tomorrow.
SHL Group is proud to exhibit at Drug Delivery Partnerships in Palm Beach Gardens, Florida on February 7-9, 2017.
At the conference, Markus Bauss, Managing Director of SHL Connect, will provide a presentation on the topic of “Connectivity in Drug Delivery & Smart Administration.”
